| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO &President | Director | EVP And CMO
2 companies
Kewalramani Reshma is a Director at DNA with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 9 sells.
Estimated insider holdings value: $59.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Buy | 10,000 | $389.58 | $3,895,767.70 | +4.6% | +9.3% | - | |
| Nov 8, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sell | 15,198 | $515.00 | $7,826,970.00 | -16.7% | -6.9% | -20.8% | |
| Jul 30, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sell | 15,202 | $505.00 | $7,677,010.00 | -14.3% | -5.2% | -6.7% | |
| Jul 22, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sell | 15,202 | $497.00 | $7,555,394.00 | -12.5% | -3.6% | -5.2% | |
| May 24, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sale+OE | 1,565 | $457.00 | $715,205.00 | -1.3% | +5.0% | -4.6% | |
| May 20, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sell | 15,202 | $447.00 | $6,795,294.00 | -11.1% | +9.5% | +0.3% | |
| Dec 15, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sale+OE | 17,135 | $407.00 | $6,973,945.00 | -13.6% | -0.5% | +12.9% | |
| Dec 13, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sell | 5,098 | $397.00 | $2,023,906.00 | -4.5% | +1.8% | +14.6% | |
| Nov 13, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sell | 5,097 | $377.00 | $1,921,569.00 | -4.3% | +10.5% | +29.3% | |
| Jul 17, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sell | 7,828 | $355.00 | $2,778,940.00 | -6.2% | +4.5% | +36.6% |